Orally Administered Particulate β-Glucan Modulates Tumor-Capturing Dendritic Cells and Improves Antitumor T-Cell Responses in Cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Cancer Research

• Publication date

  2010-09-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-10-0820PMID 20855461PMCID PMC2970627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T helper 17 cells promote cytotoxic T cell activation in tumor immunity.

  2009cited by this paper
• Endogenous IL-17 contributes to reduced tumor growth and metastasis.

  2009cited by this paper
• Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

  2009cited by this paper
• Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation

  2009cited by this paper
• Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.

  2009cited by this paper
• Effect of Yeast-derived β-glucan in Conjunction With Bevacizumab for the Treatment of Human Lung Adenocarcinoma in Subcutaneous and Orthotopic Xenograft Models

  2009cited by this paper
• A phase Ib/2, dose-escalating, safety, and efficacy study of imprime PGG, cetuximab and irinotecan in patients with advanced colorectal cancer (CRC).

  2009cited by this paper
• Plasmacytoid Dendritic Cells Regulate Autoreactive B Cell Activation via Soluble Factors and in a Cell-to-Cell Contact Manner1

  2009cited by this paper
• Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes1

  2008cited by this paper
• DC activated via dectin-1 convert Treg into IL-17 producers

  2008cited by this paper
• Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1.

  2008cited by this paper
• Mobilization of Hematopoietic Progenitor Cells by Yeast‐Derived β‐Glucan Requires Activation of Matrix Metalloproteinase‐9

  2008cited by this paper
• Yeast-Derived β-Glucan Augments the Therapeutic Efficacy Mediated by Anti–Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models

  2008cited by this paper
• Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses.

  2008cited by this paper
• β‐Glucan of Candida albicans cell wall causes the subversion of human monocyte differentiation into dendritic cells

  2007cited by this paper
• Integrin Engagement Mediates the Human Polymorphonuclear Leukocyte Response to a Fungal Pathogen-Associated Molecular Pattern1

  2007cited by this paper
• Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17

  2007cited by this paper
• Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment

  2007cited by this paper
• Immunosuppressive strategies that are mediated by tumor cells.

  2007cited by this paper
• Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways.

  2007cited by this paper
• Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.

  2007cited by this paper
• Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

  2006cited by this paper
• Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.

  2006cited by this paper
• Yeast β-Glucan Amplifies Phagocyte Killing of iC3b-Opsonized Tumor Cells via Complement Receptor 3-Syk-Phosphatidylinositol 3-Kinase Pathway1

  2006cited by this paper
• Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury.

  2006cited by this paper
• C5a-Mediated Leukotriene B4-Amplified Neutrophil Chemotaxis Is Essential in Tumor Immunotherapy Facilitated by Anti-Tumor Monoclonal Antibody and β-Glucan1

  2005cited by this paper
• Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells

  2005cited by this paper
• Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan.

  2005cited by this paper
• Yeast whole glucan particle (WGP) β-glucan in conjunction with antitumour monoclonal antibodies to treat cancer

  2005cited by this paper
• Recognition of bacterial products by toll-like receptors.

  2005cited by this paper
• Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models1

  2004influential reference
• Faculty Opinions recommendation of Dectin-1 mediates the biological effects of beta-glucans.

  2003cited by this paper
• Dr William Coley and tumour regression: a place in history or in the future.

  2003cited by this paper
• Dectin-1 Mediates the Biological Effects of β-Glucans

  2003cited by this paper
• Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2

  2003cited by this paper
• Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.

  2003cited by this paper
• Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies

  2002cited by this paper
• Human monocyte scavenger receptors are pattern recognition receptors for (1→3)‐β‐D‐glucans

  2002cited by this paper
• Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.

  2002cited by this paper
• Innate immune recognition.

  2002cited by this paper
• Immune recognition. A new receptor for beta-glucans.

  2001cited by this paper
• Immune recognition: A new receptor for β-glucans

  2001cited by this paper
• Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein.

  2000cited by this paper
• Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).

  1999cited by this paper
• The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.

  1999cited by this paper
• A Novel Carbohydrate-Glycosphingolipid Interaction between a β-(1–3)-Glucan Immunomodulator, PGG-glucan, and Lactosylceramide of Human Leukocytes*

  1998cited by this paper
• Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).

  1996cited by this paper
• NMR spectral analysis of a water-insoluble (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae.

  1994cited by this paper
• Comparative tumor‐inhibitory and anti‐bacterial activity of soluble and particulate glucan

  1979cited by this paper
• Glucan: attempts to demonstrate therapeutic activity against five syngeneic tumors in guinea pigs and mice.

  1978cited by this paper
• The effect of yeast polysaccharides on mouse tumors.

  1963cited by this paper

• The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level

  2026cites this paper
• A promising Staphylococcus aureus vaccine adjuvant candidate to overcome Staphylococcal infection based on innate immunity

  2025cites this paper
• Trained immunity: A new player in cancer immunotherapy

  2025cites this paper
• Alterations in CD8+CD45RA+CCR7- T cells as a potential biomarker for primary Sjögren's syndrome.

  2025cites this paper
• β‐1,3 Glucan Microparticles & Nanoparticles: Fabrication Methods & Applications in Immunomodulation & Targeted Drug Delivery

  2025cites this paper
• Whole glucan particles enhance immune modulation in combination with TIGIT checkpoint blockade through Dectin-1 activation.

  2025cites this paper
• β-glucan combined with PD-1/PD-L1 checkpoint blockade suppresses pancreatic tumor growth after ablation therapy

  2025cites this paper
• Comparative evaluation of β-glucan functional dressing and interferon-α2a plug for vaginal microecology restoration and HPV clearance in women with bacterial vaginosis or aerobic vaginitis.

  2025cites this paper
• The isolation, bioactivity, and role of β-glucans in health: A review.

  2025cites this paper
• Yeast-derived particulate beta-glucan induced angiogenesis via regulating PI3K/Src and ERK1/2 signaling pathway.

  2024cites this paper
• Rapamycin loaded in yeast-derived glucan particles promoted tumour cell apoptosis and the antitumour immune response in melanoma

  2024cites this paper
• Trained immunity: General and emerging concepts

  2024cites this paper
• Postbiotics of Lacticaseibacillus paracasei CECT 9610 and Lactiplantibacillus plantarum CECT 9608 attenuates store‐operated calcium entry and FAK phosphorylation in colorectal cancer cells

  2024cites this paper
• Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasally

  2024cites this paper
• Recognition of yeast β-glucan particles triggers immunometabolic signaling required for trained immunity

  2024cites this paper
• Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells

  2024cites this paper
• Harnessing traditional Chinese medicine polysaccharides for combatting COVID-19.

  2024cites this paper
• Trained immunity inducers in cancer immunotherapy

  2024cites this paper
• Enhancement of systemic virus-specific T lymphocyte responses in pigs supplemented with algae-derived β-glucan.

  2024cites this paper
• Postbiotics—A Revolution Engineering Symbiotics ofInanimate microorganisms and their components

  2024cites this paper
• The engineered agonistic anti-CD40 antibody potentiates the antitumor effects of β-glucan by resetting TAMs.

  2024cites this paper
• β-Glucan Subverts the Function of Myeloid Cells in Neonates

  2024cites this paper
• Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy

  2024cites this paper
• Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC

  2023cites this paper
• Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy.

  2023cites this paper
• Melanoma tumour‐derived glycans hijack dendritic cell subsets through C‐type lectin receptor binding

  2023cites this paper
• Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery

  2023cites this paper
• Functional immune boosters; the herb or its dead microbiome? Antigenic TLR4 agonist MAMPs found in 65 medicinal roots and algae’s

  2023cites this paper
• Yeast β-Glucan Modulates Macrophages and Improves Antitumor NK Cell Responses in Cancer.

  2023cites this paper
• Polysaccharide‑platinum complexes for cancer theranostics.

  2023cites this paper
• Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation

  2023cites this paper
• Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth

  2022cites this paper
• Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients

  2022cites this paper
• Immune State Conversion of the Mesenteric Lymph Node in a Mouse Breast Cancer Model

  2022cites this paper
• Beta-Glucan from S. cerevisiae Protected AOM-Induced Colon Cancer in cGAS-Deficient Mice Partly through Dectin-1-Manipulated Macrophage Cell Energy

  2022cites this paper
• Epigenetic Memories in Hematopoietic Stem and Progenitor Cells

  2022cites this paper
• β-glucans obtained from beer spent yeasts as functional food grade additive: Focus on biological activity

  2022cites this paper
• Narrow-Gap Rheometry: A Novel Method for Measuring Cell Mechanics

  2022cites this paper
• Inhibition of TFEB promotes tumor-educated dendritic cells activation to enhance antitumor immune responses.

  2022cites this paper
• β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer

  2022cites this paper
• Controlled modulation of all the arms of the immunity including innate immunity by biological response modifier glucans, a simple yet potential nutritional supplement strategy to fight COVID‐19

  2022cites this paper
• Ingestion, Immunity, and Infection: Nutrition and Viral Respiratory Tract Infections

  2022cites this paper
• Advances in oral absorption of polysaccharides: Mechanism, affecting factors, and improvement strategies.

  2022cites this paper
• Pb intoxicated biomolecular changes in Cladonia convoluta studied using 2DCOS Infrared spectroscopy coupled with chemometric analysis

  2022cites this paper
• β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19

  2021cites this paper
• From Pre- and Probiotics to Post-Biotics: A Narrative Review

  2021cites this paper
• Crosstalk between macrophages and natural killer cells in the tumor microenvironment.

  2021cites this paper
• Brewer's yeast polysaccharides - A review of their exquisite structural features and biomedical applications.

  2021cites this paper
• Beta-d-glucan-based drug delivery system and its potential application in targeting tumor associated macrophages.

  2021cites this paper
• Trained immunity in the mucosal diseases.

  2021cites this paper
• Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review

  2021cites this paper
• Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression

  2021cites this paper
• CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma

  2021cites this paper
• Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.

  2020cites this paper
• Key genes and pathways in tumor‐educated dendritic cells by bioinformatical analysis

  2020cites this paper
• Antitumor effects of targeting myeloid-derived suppressive cells

  2020cites this paper
• Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?

  2020cites this paper
• Postbiotics—A Step Beyond Pre- and Probiotics

  2020cites this paper
• Curdlan, zymosan and a yeast-derived β-glucan reshape tumor-associated macrophages into producers of inflammatory chemo-attractants

  2020cites this paper
• Covid-19: Perspectives on Innate Immune Evasion

  2020cites this paper
• Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity

  2020cites this paper
• Anti-tumor activity and immunogenicity of a succinoglycan riclin.

  2020cites this paper
• Yeast (1 → 3)-(1 → 6)-β-d-glucan alleviates immunosuppression in gemcitabine-treated mice.

  2019cites this paper
• Inhibition of tumor growth by β-glucans through promoting CD4+ T cell immunomodulation and neutrophil-killing in mice.

  2019cites this paper
• Yeast-Derived β-Glucan in Cancer: Novel Uses of a Traditional Therapeutic

  2019cites this paper
• Leveraging biomaterials for cancer immunotherapy: targeting pattern recognition receptors

  2019cites this paper
• C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets

  2018cites this paper
• Tumor exosomes block dendritic cells maturation to decrease the T cell immune response.

  2018cites this paper
• Consumption of β-glucans to spice up T cell treatment of tumors: a review

  2018influential citation
• Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung

  2018cites this paper
• β-Glucan induces autophagy in dendritic cells and influences T-cell differentiation

  2018cites this paper
• Cancer Chemopreventive, Antiproliferative, and Superoxide Anion Scavenging Properties of Kluyveromyces marxianus and Saccharomyces cerevisiae var. boulardii Cell Wall Components

  2018cites this paper
• β-glucans as potential immunoadjuvants: A review on the adjuvanticity, structure-activity relationship and receptor recognition properties.

  2018cites this paper
• Effect of Saccharomyces Boulardii Cell Wall Extracts on Colon Cancer Prevention in Male F344 Rats Treated with 1,2-Dimethylhydrazine

  2018cites this paper
• Regulation of Gene Expression by β-Glucans

  2017cites this paper
• Zymosan A enhances humoral immune responses to soluble protein in chickens

  2017cites this paper
• The effect of Saccharomyces cerevisiae β-glucan on proliferation, phagocytosis and cytokine production of murine macrophages and dendritic cells

  2017cites this paper
• Lung cancer and β-glucans: review of potential therapeutic applications

  2017cites this paper
• Uptake of intraperitoneally administrated triple helical β-glucan for antitumor activity in murine tumor models.

  2017cites this paper
• Differentiation to APC in Cancer Apoptosis and Monocytic MDSC by Inducing Polymorphonuclear MDSC Myeloid-Derived Suppressor Cells ( MDSC ) Treatment Subverts the Suppression of-Glucan β Yeast-Derived Particulate

  2016cites this paper
• Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity

  2016cites this paper
• Beta-glucan contamination of pharmaceutical products: How much should we accept?

  2016cites this paper
• Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer

  2016cites this paper
• β‐glucan restores tumor‐educated dendritic cell maturation to enhance antitumor immune responses

  2016cites this paper
• β-Glucan enhances cytotoxic T lymphocyte responses by activation of human monocyte-derived dendritic cells via the PI3K/AKT pathway.

  2015cites this paper
• Oral Administered Particulate Yeast-Derived Glucan Promotes Hepatitis B Virus Clearance in a Hydrodynamic Injection Mouse Model

  2015cites this paper
• Immunomodulation of myeloid-derived suppressor cells by particulate b-glucan in cancer.

  2015influential citation
• MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1

  2015cites this paper
• Particulate β-glucan regulates the immunosuppression of granulocytic myeloid-derived suppressor cells by inhibiting NFIA expression

  2015cites this paper
• Cells via Targeting Runx1 and Function of Myeloid-Derived Suppressor MicroRNA-9 Regulates the Differentiation

  2015cites this paper
• Targeting C-Type Lectin Receptors for Cancer Immunity

  2015cites this paper
• Particulate yeast β-glucan is internalized by RAW 264.7 macrophages and reduces the activity of the tumor-associated protease legumain

  2015cites this paper
• The Immunostimulating Role of Lichen Polysaccharides: A Review

  2015cites this paper
• Effect of beta glucan on white blood cell counts and serum levels of IL-4 and IL-12 in women with breast cancer undergoing chemotherapy: a randomized double-blind placebo-controlled clinical trial.

  2014cites this paper
• Recent advances in oral vaccine development

  2014cites this paper
• Heat treatment improves antigen-specific T cell activation after protein delivery by several but not all yeast genera.

  2014cites this paper
• Activation of antitumor immune responses by Ganoderma formosanum polysaccharides in tumor-bearing mice

  2014cites this paper
• Effects of orally administered yeast-derived beta-glucans: a review.

  2014cites this paper
• Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2

  2014cites this paper
• The application of fungal β-glucans for the treatment of colon cancer.

  2013cites this paper